A H Gamanga1, P Owiti2,3, P Bhat4, A D Harries3,5, I Kargbo-Labour6, M Koroma6. 1. Bonthe Government Hospital, Ministry of Health and Sanitation (MoHS), Bonthe Sherbro Island, Bonthe District, Sierra Leone. 2. Academic Model Providing Access to Health Care (AMPATH), Eldoret, Kenya. 3. International Union Against Tuberculosis and Lung Disease, Paris, France. 4. Ministry of Health, Government of Karnataka, Mangalore, India. 5. London School of Hygiene & Tropical Medicine, London, UK. 6. MoHS, Mattru Jong, Bonthe District, Sierra Leone.
Abstract
Setting: All public health facilities in Bonthe District, rural Sierra Leone. Objective: To compare, in the periods before and during the Ebola virus disease outbreak, 1) the submission and completeness of monthly human immunodeficiency virus (HIV) reports, and 2) the uptake of HIV testing and care for pregnant women and the general population. Design: A cross-sectional study using routine programme data. Results: Of the 627 HIV reports expected in each period, 406 (65%) were submitted in the pre-Ebola period and 376 (60%) during the Ebola outbreak (P = 0.08), of which respectively 318 (78%) and 335 (89%) had complete information (P < 0.001). In the pre-Ebola period, 5012 pregnant women underwent testing for HIV, of whom 25 were HIV-positive, compared to 4254 during the Ebola period, of whom 21 were HIV-positive (P < 0.001). Of those who were HIV-positive, respectively 14 (56%) and 21 (100%) received antiretroviral prophylaxis or antiretroviral therapy (ART) (P < 0.001). In the general population, 5770 persons underwent HIV testing pre-Ebola vs. 3095 in the Ebola period (P < 0.001); of those who tested positive for HIV, respectively 62% (33/53) and 81% (33/41) were started on ART (P = 0.06). Conclusion: There was suboptimal reporting on HIV/acquired immune-deficiency disease syndrome activities before and during the Ebola virus disease outbreak. HIV testing decreased during the Ebola outbreak, while the uptake of prevention of mother-to-child transmission and ART increased. Pre-emptive actions are needed to maintain the levels of HIV testing in any future outbreak.
Setting: All public health facilities in Bonthe District, rural Sierra Leone. Objective: To compare, in the periods before and during the Ebola virus disease outbreak, 1) the submission and completeness of monthly human immunodeficiency virus (HIV) reports, and 2) the uptake of HIV testing and care for pregnant women and the general population. Design: A cross-sectional study using routine programme data. Results: Of the 627 HIV reports expected in each period, 406 (65%) were submitted in the pre-Ebola period and 376 (60%) during the Ebola outbreak (P = 0.08), of which respectively 318 (78%) and 335 (89%) had complete information (P < 0.001). In the pre-Ebola period, 5012 pregnant women underwent testing for HIV, of whom 25 were HIV-positive, compared to 4254 during the Ebola period, of whom 21 were HIV-positive (P < 0.001). Of those who were HIV-positive, respectively 14 (56%) and 21 (100%) received antiretroviral prophylaxis or antiretroviral therapy (ART) (P < 0.001). In the general population, 5770 persons underwent HIV testing pre-Ebola vs. 3095 in the Ebola period (P < 0.001); of those who tested positive for HIV, respectively 62% (33/53) and 81% (33/41) were started on ART (P = 0.06). Conclusion: There was suboptimal reporting on HIV/acquired immune-deficiency disease syndrome activities before and during the Ebola virus disease outbreak. HIV testing decreased during the Ebola outbreak, while the uptake of prevention of mother-to-child transmission and ART increased. Pre-emptive actions are needed to maintain the levels of HIV testing in any future outbreak.
Entities:
Keywords:
PMTCT; SORT IT; antiretroviral therapy; operational research; pregnant women
Authors: M Edginton; D Enarson; R Zachariah; T Reid; S Satyanarayana; K Bissell; S G Hinderaker; T Harries Journal: Public Health Action Date: 2012-03-21
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: David Leuenberger; Jean Hebelamou; Stefan Strahm; Nathalie De Rekeneire; Eric Balestre; Gilles Wandeler; François Dabis Journal: AIDS Date: 2015-09-10 Impact factor: 4.177
Authors: Gerald P Douglas; Oliver J Gadabu; Sabine Joukes; Soyapi Mumba; Michael V McKay; Anne Ben-Smith; Andreas Jahn; Erik J Schouten; Zach Landis Lewis; Joep J van Oosterhout; Theresa J Allain; Rony Zachariah; Selma D Berger; Anthony D Harries; Frank Chimbwandira Journal: PLoS Med Date: 2010-08-10 Impact factor: 11.069
Authors: Augustine Talumba Choko; Nicola Desmond; Emily L Webb; Kondwani Chavula; Sue Napierala-Mavedzenge; Charlotte A Gaydos; Simon D Makombe; Treza Chunda; S Bertel Squire; Neil French; Victor Mwapasa; Elizabeth L Corbett Journal: PLoS Med Date: 2011-10-04 Impact factor: 11.069
Authors: Joel D Bognini; Sekou Samadoulougou; Mady Ouedraogo; Tiga David Kangoye; Carine Van Malderen; Halidou Tinto; Fati Kirakoya-Samadoulougou Journal: Int J Equity Health Date: 2021-05-21
Authors: Jessica E Long; McKenna C Eastment; George Wanje; Barbra A Richardson; Emily Mwaringa; Mwanakarama Athman Mohamed; Kenneth Sherr; Ruanne V Barnabas; Kishorchandra Mandaliya; Walter Jaoko; R Scott McClelland Journal: Implement Sci Date: 2022-10-04 Impact factor: 7.960
Authors: Pruthu Thekkur; Kudakwashe C Takarinda; Collins Timire; Charles Sandy; Tsitsi Apollo; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-31
Authors: Seid Getahun Abdela; Abel Balcha Berhanu; Leul Mesfin Ferede; Johan van Griensven Journal: Am J Trop Med Hyg Date: 2020-09 Impact factor: 2.345
Authors: Irene Mbithi; Pruthu Thekkur; Jeremiah Muhwa Chakaya; Elizabeth Onyango; Philip Owiti; Ngugi Catherine Njeri; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-10
Authors: Pruthu Thekkur; Hannock Tweya; Sam Phiri; James Mpunga; Thokozani Kalua; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-19
Authors: George A Yendewa; Sulaiman Lakoh; Sahr A Yendewa; Khadijah Bangura; Andrés Tabernilla; Lucia Patiño; Darlinda F Jiba; Alren O Vandy; Samuel P Massaquoi; Nuno S Osório; Gibrilla F Deen; Foday Sahr; Robert A Salata; Eva Poveda Journal: Genes (Basel) Date: 2021-08-26 Impact factor: 4.096